Differential regulation of human T lymphoblast functions by IL-2 and IL-15

被引:51
作者
BulfonePaus, S
Durkop, H
Paus, R
Krause, H
Pohl, T
Onu, A
机构
[1] FREE UNIV BERLIN,HOSP BENJAMIN FRANKLIN,INST PATHOL,D-12203 BERLIN,GERMANY
[2] FREE UNIV BERLIN,HOSP BENJAMIN FRANKLIN,INST UROL,D-12203 BERLIN,GERMANY
[3] HUMBOLDT UNIV BERLIN,DEPT DERMATOL,D-10117 BERLIN,GERMANY
关键词
IL-15; IL-2; human T lymphoblasts;
D O I
10.1006/cyto.1996.0194
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interleukin 15 (IL-15) shares many functional properties with interleukin 2 (IL-2), although both cytokines probably also exert distinct functions. In order to screen for functional differences between IL-2 and IL-15 with respect to the control of T cell functions, we have stimulated human T lymphoblasts (hTBl) with IL-2 and/or IL-15 and have assessed the resulting changes in the following parameters: T cell proliferation; expression of various relevant surface markers; cytokine and receptor (alpha-chain) transcription; and IL-2 and 1L-15 activity. Both cytokines equally upregulate standard activation markers such as CD25 and CD95 and downregulate CD27. However, IL-2 upregulates CD30, TNF receptor type II and CD40L expression significantly stronger than IL-15. IL-15 potentiates Con A-induced IL-2 secretion. Even though hTBl transcribe the IL-15 gene, they do not secrete IL-15 activity. These observations suggest that both cytokines can differentially regulate T cells, e.g. T cell functions relevant to the control of cell cycle progression and apoptosis, and/or that they can stimulate different T cell subsets. Moreover, IL-15 may potentiate IL-2-driven T cell responses. (C) 1997 Academic Press Limited.
引用
收藏
页码:507 / 513
页数:7
相关论文
共 27 条
[1]  
ALZONA M, 1995, J IMMUNOL, V154, P9
[2]  
ANDERSON DM, 1995, J BIOL CHEM, V270, P29862
[3]  
ARMITAGE RJ, 1995, J IMMUNOL, V154, P483
[4]  
BAINE Y, 1995, J IMMUNOL, V154, P3667
[5]   THE INTERLEUKIN (IL)-2 RECEPTOR-BETA CHAIN IS SHARED BY IL-2 AND A CYTOKINE, PROVISIONALLY DESIGNATED IL-T, THAT STIMULATES T-CELL PROLIFERATION AND THE INDUCTION OF LYMPHOKINE-ACTIVATED KILLER-CELLS [J].
BAMFORD, RN ;
GRANT, AJ ;
BURTON, JD ;
PETERS, C ;
KURYS, G ;
GOLDMAN, CK ;
BRENNAN, J ;
ROESSLER, E ;
WALDMANN, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) :4940-4944
[6]   A LYMPHOKINE, PROVISIONALLY DESIGNATED INTERLEUKIN-T AND PRODUCED BY A HUMAN ADULT T-CELL LEUKEMIA LINE, STIMULATES T-CELL PROLIFERATION AND THE INDUCTION OF LYMPHOKINE-ACTIVATED KILLER-CELLS [J].
BURTON, JD ;
BAMFORD, RN ;
PETERS, C ;
GRANT, AJ ;
KURYS, G ;
GOLDMAN, CK ;
BRENNAN, J ;
ROESSLER, E ;
WALDMANN, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) :4935-4939
[7]   INTERLEUKIN (IL)-15 IS A NOVEL CYTOKINE THAT ACTIVATES HUMAN NATURAL-KILLER-CELLS VIA COMPONENTS OF THE IL-2 RECEPTOR [J].
CARSON, WE ;
GIRI, JG ;
LINDEMANN, MJ ;
LINETT, ML ;
AHDIEH, M ;
PAXTON, R ;
ANDERSON, D ;
EISENMANN, J ;
GRABSTEIN, K ;
CALIGIURI, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 180 (04) :1395-1403
[8]   CYTOKINE ANTAGONISTS AND THEIR POTENTIAL THERAPEUTIC USE [J].
DEBETS, R ;
SAVELKOUL, HFJ .
IMMUNOLOGY TODAY, 1994, 15 (10) :455-458
[9]  
DiSanto JP, 1995, IMMUNOL REV, V148, P19
[10]  
GAMERO AM, 1995, CANCER RES, V55, P4988